# K202150: GlidePath 7.5F Long-Term Dialysis Catheter

- Pathway: 510(k) (Traditional)
- Applicant: C.R. Bard, Inc.
- Decided: Nov 18, 2020 after 107 days
- Product code: MSD (Catheter, Hemodialysis, Implanted)
- Device class: 2
- Regulation: 21 CFR 876.5540
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 8 generations back to K981994 (1998). 13 ancestors in all.
1 later device descends from it; 1 cites it directly.
1 of 15 devices in its family (counting itself) has a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K200627: GlidePath 10F Long-Term Dialysis Catheter, C.R. Bard, Inc. (2020) Summary page 4.

## Most influential descendants
- K241581: Hemodialysis Catheter (2025), 0 descendants of its own

## Indications for use
The GlidePath™ 7.5F Long-Term Hemodialysis Catheter is indicated for use in attaining short-term or long-term vascular access in pediatric, adolescent, and adult patients for hemodialysis, hemoperfusion or apheresis as determined by the prescribing physician. Access is attained via the internal jugular vein, subclavian vein, or femoral vein.

Source page: https://510kreport.com/device/K202150
Methodology: https://510kreport.com/methodology